The supraventricular tachycardia physiology
The supraventricular tachycardia physiology Supraventricular tachycardia (SVT) is a common cardiac arrhythmia characterized by an abnormally rapid heart rate originating above the ventricles. Typically, heart rates in SVT range from 150 to 250 beats per minute, which can lead to symptoms such as palpitations, dizziness, shortness of breath, and sometimes chest discomfort. Understanding the physiology behind SVT involves exploring the electrical conduction system of the heart and the mechanisms that trigger abnormal rapid rhythms.
The heart’s electrical system is responsible for initiating and coordinating contractions that pump blood effectively throughout the body. This system consists of the sinoatrial (SA) node, atrioventricular (AV) node, bundle of His, and Purkinje fibers. Under normal circumstances, electrical impulses originate in the SA node, the heart’s natural pacemaker, and propagate through the atria to the AV node. From there, impulses travel to the ventricles, causing coordinated contractions. This orderly process maintains a steady heart rate and rhythm.
In SVT, the issue arises when there is an abnormal electrical circuit or focus within the atria or the region near the AV node. One common mechanism involves reentry, a process where an electrical impulse continuously loops within a circuit, repeatedly activating the heart tissue. Reentrant circuits can form when there are areas of the heart with different conduction velocities or refractory periods, creating a pathway that allows the impulse to re-excite tissue after a delay. This leads to rapid, repetitive activation of the atria or the atrioventricular junction, resulting in tachycardia. The supraventricular tachycardia physiology
Another mechanism involves enhanced automaticity, where an ectopic focus within the atria or near the AV node spontaneously depolarizes at a rate faster than the SA node, overriding the normal pacemaker activity. This can lead to a sudden onset of rapid heart rhythm without a reentrant circuit. The supraventricular tachycardia physiology
The supraventricular tachycardia physiology Certain structural and functional conditions predispose individuals to SVT, including accessory pathways—abnormal conduction pathways that bypass the normal electrical route. The most well-known example is Wolff-Parkinson-White (WPW) syndrome, where an accessory pathway allows impulses to bypass the AV node, facilitating reentrant tachycardia.
Electrophysiological studies can identify the specific mechanisms and pathways involved, guiding treatment strategies. For example, medications such as beta-blockers and calcium channel blockers can slow conduction and suppress episodes. In some cases, catheter ablation—a procedure that destroys abnormal pathways—may offer a permanent cure.
Understanding the physiological basis of SVT highlights the importance of the heart’s electrical system in maintaining normal rhythm and how subtle alterations can lead to significant arrhythmias. While SVT can be alarming, most episodes are manageable and treatable, especially with advances in electrophysiology that allow for targeted interventions. The supraventricular tachycardia physiology
The supraventricular tachycardia physiology In summary, supraventricular tachycardia results from abnormal electrical activity within the heart’s conduction system, predominantly through reentrant circuits or ectopic automaticity, often facilitated by accessory pathways or conduction abnormalities. Recognizing these mechanisms is crucial for effective diagnosis and management.
